{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:20:46Z","timestamp":1783693246625,"version":"3.55.0"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017590","name":"Universit\u00e4tsklinikum Essen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017590","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Eating disorders (EDs) have complex presentations with high rates of comorbidities and low recovery rates. Current treatment options often lack sufficiency in improving ED symptoms. Psychedelic-assisted therapies represent a novel treatment approach for the treatment of EDs, with research documenting preliminary positive evidence. However, psychedelics have their own challenges and risks which need to be considered within an ED population to inform study design and future clinical application. The primary aim of this meta-synthesis was to integrate existing qualitative data on the experience of using psychedelics in ED treatment from the perspectives of both individuals with EDs and providers (e.g. clinicians, ceremony leaders), using meta-ethnography to generate new interpretative insights.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The methods followed the seven steps of a meta ethnographic approach. An electronic search of three databases (PubMed, Medline, and PsycINFO) was conducted. Papers were included if they were qualitative studies exploring the use of typical or atypical psychedelics, from the perspective of either a provider or individual experiencing an ED.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of eight studies were included. From the data we identified five meta-themes that together depict how psychedelic experiences may act as catalysts for transformation. Our interpretive narrative posits that core transformative processes (Mind-Body-Spirit, Emotional Processing), unfold within specific contextual conditions (Navigating Challenges and Risks, Enabling Safe and Supportive Experiences), and lead to meaningful outcomes (Therapeutic Improvements). Meta- and sub-themes reflect ED-specific elements, highlighting that psychedelics may improve emotion processing and enhance perception of and connection with the body and the self, which is pertinent to ED recovery. Themes also indicate the increased risk for adverse side effects with low weight and other physical vulnerabilities associated with EDs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The themes and interpretive narratives identified in this meta-synthesis suggest that to achieve therapeutic outcomes, ED-specific contextual conditions are required to facilitate internal processes during psychedelic therapy for EDs. This includes minimising the uncertainty that typifies EDs through exploration of expectations and autonomy in selection of setting elements (e.g. lighting, music, eye-mask) or collaboratively agreeing strategies for if anxiety spikes. Further, facilitators should require dual competency in psychedelic treatment and ED psychopathology and treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-026-04929-2","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T03:33:51Z","timestamp":1779161631000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding experiences of psychedelic treatments for eating disorders: a meta-synthesis of qualitative studies"],"prefix":"10.1186","volume":"24","author":[{"given":"Rebecca","family":"Morris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse","family":"Gundogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubertus","family":"Himmerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Treasure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna L.","family":"Keeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"4929_CR1","doi-asserted-by":"publisher","first-page":"152468","DOI":"10.1016\/j.comppsych.2024.152468","volume":"131","author":"E Tomba","year":"2024","unstructured":"Tomba E, Tecuta L, Gardini V, Tomei G, Lo Dato E. Staging models in eating disorders: A systematic scoping review of the literature. Compr Psychiatry. 2024;131:152468.","journal-title":"Compr Psychiatry"},{"key":"4929_CR2","unstructured":"World Health Organisation. ICD-11: International classification of diseases (11th revision) 2022 [Available from: https:\/\/icd.who.int\/"},{"issue":"5","key":"4929_CR3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/erv.2532","volume":"25","author":"TA Brown","year":"2017","unstructured":"Brown TA, Berner LA, Jones MD, Reilly EE, Cusack A, Anderson LK, et al. Psychometric Evaluation and Norms for the Multidimensional Assessment of Interoceptive Awareness (MAIA) in a Clinical Eating Disorders Sample. Eur Eat Disord Rev. 2017;25(5):411\u20136.","journal-title":"Eur Eat Disord Rev"},{"issue":"3","key":"4929_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/87568225.2010.486291","volume":"24","author":"AM Wagener","year":"2010","unstructured":"Wagener AM, Much K. Eating disorders as coping mechanisms. J Coll Stud Psychother. 2010;24(3):203\u201312.","journal-title":"J Coll Stud Psychother"},{"key":"4929_CR5","doi-asserted-by":"publisher","first-page":"101426","DOI":"10.1016\/j.eatbeh.2020.101426","volume":"39","author":"AG Vida\u00f1a","year":"2020","unstructured":"Vida\u00f1a AG, Forbush KT, Barnhart EL, Mildrum Chana S, Chapa DAN, Richson B, et al. Impact of trauma in childhood and adulthood on eating-disorder symptoms. Eat Behav. 2020;39:101426.","journal-title":"Eat Behav"},{"issue":"2","key":"4929_CR6","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.psychres.2015.09.008","volume":"230","author":"S Ulfvebrand","year":"2015","unstructured":"Ulfvebrand S, Birgeg\u00e5rd A, Norring C, H\u00f6gdahl L, von Hausswolff-Juhlin Y. Psychiatric comorbidity in women and men with eating disorders results from a large clinical database. Psychiatry Res. 2015;230(2):294\u20139.","journal-title":"Psychiatry Res"},{"issue":"1","key":"4929_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.cpr.2010.08.003","volume":"31","author":"PE Jenkins","year":"2011","unstructured":"Jenkins PE, Hoste RR, Meyer C, Blissett JM. Eating disorders and quality of life: A review of the literature. Clin Psychol Rev. 2011;31(1):113\u201321.","journal-title":"Clin Psychol Rev"},{"issue":"null","key":"4929_CR8","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.2147\/NDT.S199927","volume":"15","author":"A Grau","year":"2019","unstructured":"Grau A, Magall\u00f3n-Neri E, Faus G, Feixas G. Cognitive impairment in eating disorder patients of short and long-term duration: a case\u2013control study. Neuropsychiatr Dis Treat. 2019;15(null):1329\u201341.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"7","key":"4929_CR9","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1001\/archgenpsychiatry.2011.74","volume":"68","author":"J Arcelus","year":"2011","unstructured":"Arcelus J, Mitchell AJ, Wales J, Nielsen S. Mortality Rates in Patients With Anorexia Nervosa and Other Eating Disorders: A Meta-analysis of 36 Studies. Arch Gen Psychiatry. 2011;68(7):724\u201331.","journal-title":"Arch Gen Psychiatry"},{"key":"4929_CR10","unstructured":"National Institute for Health and Care Excellence. Eating disorders: recognition and treatment. 2017."},{"issue":"1","key":"4929_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1891\/0889-8391.28.1.48","volume":"28","author":"U Schmidt","year":"2014","unstructured":"Schmidt U, Wade TD, Treasure J. The Maudsley Model of Anorexia Nervosa Treatment for Adults (MANTRA): Development, Key Features, and Preliminary Evidence. J Cogn Psychother. 2014;28(1):48\u201371.","journal-title":"J Cogn Psychother"},{"issue":"3","key":"4929_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S2215-0366(20)30566-6","volume":"8","author":"M Solmi","year":"2021","unstructured":"Solmi M, Wade TD, Byrne S, Del Giovane C, Fairburn CG, Ostinelli EG, et al. Comparative efficacy and acceptability of psychological interventions for the treatment of adult outpatients with anorexia nervosa: a systematic review and network meta-analysis. Lancet Psychiatry. 2021;8(3):215\u201324.","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"4929_CR13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/erv.2683","volume":"27","author":"E van den Berg","year":"2019","unstructured":"van den Berg E, Houtzager L, de Vos J, Daemen I, Katsaragaki G, Karyotaki E, et al. Meta-analysis on the efficacy of psychological treatments for anorexia nervosa. Eur Eat Disord Rev. 2019;27(4):331\u201351.","journal-title":"Eur Eat Disord Rev"},{"issue":"8","key":"4929_CR14","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1080\/15622975.2023.2179663","volume":"24","author":"H Himmerich","year":"2023","unstructured":"Himmerich H, Lewis YD, Conti C, Mutwalli H, Karwautz A, Sj\u00f6gren JM, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines update 2023 on the pharmacological treatment of eating disorders. World J Biol Psychiatry. 2023;24(8):643\u2013706.","journal-title":"World J Biol Psychiatry"},{"key":"4929_CR15","doi-asserted-by":"publisher","first-page":"111077","DOI":"10.1016\/j.jpsychores.2022.111077","volume":"164","author":"L Clausen","year":"2023","unstructured":"Clausen L, Semark BD, Helverskov J, Bulik CM, Petersen LV. Pharmacotherapy in anorexia nervosa: A Danish nation-wide register-based study. J Psychosom Res. 2023;164:111077.","journal-title":"J Psychosom Res"},{"key":"4929_CR16","volume-title":"pharmacological treatment of depression in anorexia nervosa and underweight patients: A systematic review [press release]","author":"The efficacy of","year":"2025","unstructured":"The efficacy of. pharmacological treatment of depression in anorexia nervosa and underweight patients: A systematic review [press release]. US: Wiley; 2025."},{"key":"4929_CR17","doi-asserted-by":"publisher","first-page":"107782","DOI":"10.1016\/j.phrs.2025.107782","volume":"216","author":"R Morris","year":"2025","unstructured":"Morris R, Keeler J, Treasure J, Himmerich H. The pharmacological treatment of anxiety in people with eating disorders: A systematic review. Pharmacol Res. 2025;216:107782.","journal-title":"Pharmacol Res"},{"issue":"4","key":"4929_CR18","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1080\/09540261.2019.1571995","volume":"31","author":"H Himmerich","year":"2019","unstructured":"Himmerich H, Bentley J, Lichtblau N, Brennan C, Au K. Facets of shared decision-making on drug treatment for adults with an eating disorder. Int Rev Psychiatry. 2019;31(4):332\u201346.","journal-title":"Int Rev Psychiatry"},{"issue":"5","key":"4929_CR19","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1002\/eat.23495","volume":"54","author":"HP Eielsen","year":"2021","unstructured":"Eielsen HP, Vrabel K, Hoffart A, R\u00f8 \u00d8, Rosenvinge JH. The 17-year outcome of 62 adult patients with longstanding eating disorders\u2014A prospective study. Int J Eat Disord. 2021;54(5):841\u201350.","journal-title":"Int J Eat Disord"},{"key":"4929_CR20","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/1471-244X-13-294","volume":"13","author":"G Abbate-Daga","year":"2013","unstructured":"Abbate-Daga G, Amianto F, Delsedime N, De-Bacco C, Fassino S. Resistance to treatment and change in anorexia nervosa [corrected]: a clinical overview. BMC Psychiatry. 2013;13:294.","journal-title":"BMC Psychiatry"},{"issue":"1","key":"4929_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40337-022-00568-z","volume":"10","author":"C Vinchenzo","year":"2022","unstructured":"Vinchenzo C, Lawrence V, McCombie C. Patient perspectives on premature termination of eating disorder treatment: a systematic review and qualitative synthesis. J Eat Disord. 2022;10(1):39.","journal-title":"J Eat Disord"},{"issue":"6","key":"4929_CR22","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/YCO.0000000000000964","volume":"37","author":"H Himmerich","year":"2024","unstructured":"Himmerich H, Keeler JL, Tchanturia K, Treasure J. Treatment escalation for people with anorexia nervosa: setting, therapies and nutritional interventions. Curr Opin Psychiatry. 2024;37(6):404\u201316.","journal-title":"Curr Opin Psychiatry"},{"issue":"12","key":"4929_CR23","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s11920-022-01394-5","volume":"24","author":"N Gukasyan","year":"2022","unstructured":"Gukasyan N, Schreyer CC, Griffiths RR, Guarda AS. Psychedelic-Assisted Therapy for People with Eating Disorders. Curr Psychiatry Rep. 2022;24(12):767\u201375.","journal-title":"Curr Psychiatry Rep"},{"issue":"7","key":"4929_CR24","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s00213-024-06599-5","volume":"242","author":"MA Atiq","year":"2025","unstructured":"Atiq MA, Baker MR, Voort JLV, Vargas MV, Choi DS. Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties. Psychopharmacology. 2025;242(7):1481\u2013506.","journal-title":"Psychopharmacology"},{"issue":"5","key":"4929_CR25","first-page":"464","volume":"9","author":"MA Geyer","year":"2024","unstructured":"Geyer MA. A Brief Historical Overview of Psychedelic Research. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024;9(5):464\u201371.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"issue":"4","key":"4929_CR26","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1021\/acsptsci.5c00094","volume":"8","author":"S Hu","year":"2025","unstructured":"Hu S, Lin C, Wang H, Wang X. Psychedelics and Eating Disorders: Exploring the Therapeutic Potential for Anorexia Nervosa and Beyond. ACS Pharmacol Transl Sci. 2025;8(4):910\u20136.","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"1","key":"4929_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/02698811221140009","volume":"37","author":"N Ledwos","year":"2023","unstructured":"Ledwos N, Rodas JD, Husain MI, Feusner JD, Castle DJ. Therapeutic uses of psychedelics for eating disorders and body dysmorphic disorder. J Psychopharmacol. 2023;37(1):3\u201313.","journal-title":"J Psychopharmacol"},{"key":"4929_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pbr.2018.09.013","volume":"242","author":"T Calvey","year":"2018","unstructured":"Calvey T, Howells FM. An introduction to psychedelic neuroscience. Prog Brain Res. 2018;242:1\u201323.","journal-title":"Prog Brain Res"},{"issue":"4","key":"4929_CR29","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47(4):351\u20134.","journal-title":"Biol Psychiatry"},{"key":"4929_CR30","doi-asserted-by":"publisher","first-page":"111461","DOI":"10.1016\/j.pnpbp.2025.111461","volume":"141","author":"K Askariyan","year":"2025","unstructured":"Askariyan K, Joghataei MT, Dehghan S, Nohesara S, Riahi pour L, Mohammadi MH, et al. An overview of psilocybin, LSD, MDMA, and ketamine in revitalizing psychedelic-assisted therapy: Insights, limitations and future directions. Prog Neuropsychopharmacol Biol Psychiatry. 2025;141:111461.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4","key":"4929_CR31","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s40519-020-01000-8","volume":"26","author":"MJ Spriggs","year":"2021","unstructured":"Spriggs MJ, Kettner H, Carhart-Harris RL. Positive effects of psychedelics on depression and wellbeing scores in individuals reporting an eating disorder. Eat Weight Disord. 2021;26(4):1265\u201370.","journal-title":"Eat Weight Disord"},{"issue":"2","key":"4929_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/acps.13249","volume":"143","author":"KAA Andersen","year":"2021","unstructured":"Andersen KAA, Carhart-Harris R, Nutt DJ, Erritzoe D. Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies. Acta Psychiatr Scand. 2021;143(2):101\u201318.","journal-title":"Acta Psychiatr Scand"},{"key":"4929_CR33","doi-asserted-by":"crossref","unstructured":"Keeler JL, Treasure J, Juruena MF, Kan C, Himmerich H. Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review. Nutrients. 2021;13(11).","DOI":"10.3390\/nu13114158"},{"issue":"4","key":"4929_CR34","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1353\/ken.2022.0022","volume":"32","author":"N Devenot","year":"2022","unstructured":"Devenot N, Seale-Feldman A, Smith E, Noorani T, Garcia-Romeu A, Johnson MW. Psychedelic Identity Shift: A Critical Approach to Set And Setting. Kennedy Inst Ethics J. 2022;32(4):359\u201399.","journal-title":"Kennedy Inst Ethics J"},{"key":"4929_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.euroneuro.2023.05.008","volume":"75","author":"A Calder","year":"2023","unstructured":"Calder A, Mock S, Friedli N, Pasi P, Hasler G. Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms. Eur Neuropsychopharmacol. 2023;75:1\u201314.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"7","key":"4929_CR36","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1177\/0269881118754710","volume":"32","author":"RL Carhart-Harris","year":"2018","unstructured":"Carhart-Harris RL, Roseman L, Haijen E, Erritzoe D, Watts R, Branchi I, et al. Psychedelics and the essential importance of context. J Psychopharmacol. 2018;32(7):725\u201331.","journal-title":"J Psychopharmacol"},{"issue":"1","key":"4929_CR37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s40337-025-01313-y","volume":"13","author":"CL Dahlgren","year":"2025","unstructured":"Dahlgren CL, Tverrli E, Stewart LH. Reconnecting through dissociation: a 5-month follow-up case study on ketamine-assisted psychotherapy for anorexia nervosa. J Eat Disord. 2025;13(1):107.","journal-title":"J Eat Disord"},{"issue":"3","key":"4929_CR38","doi-asserted-by":"publisher","first-page":"373","DOI":"10.26502\/fjwhd.2644-28840044","volume":"3","author":"E Dechant","year":"2020","unstructured":"Dechant E, Boyle B, Ross RA. Ketamine in a patient with comorbid anorexia and MDD. J Women\u2019s Health Dev. 2020;3(3):373\u20135.","journal-title":"J Women\u2019s Health Dev"},{"issue":"7","key":"4929_CR39","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/qjmed\/91.7.493","volume":"91","author":"IH Mills","year":"1998","unstructured":"Mills IH, Park GR, Manara AR, Merriman RJ. Treatment of compulsive behaviour in eating disorders with intermittent ketamine infusions. QJM. 1998;91(7):493\u2013503.","journal-title":"QJM"},{"key":"4929_CR40","doi-asserted-by":"publisher","first-page":"764112","DOI":"10.3389\/fpsyt.2021.764112","volume":"12","author":"A Ragnhildstveit","year":"2021","unstructured":"Ragnhildstveit A, Jackson LK, Cunningham S, Good L, Tanner Q, Roughan M, et al. Case Report: Unexpected Remission From Extreme and Enduring Bulimia Nervosa With Repeated Ketamine Assisted Psychotherapy. Front Psychiatry. 2021;12:764112.","journal-title":"Front Psychiatry"},{"issue":"1","key":"4929_CR41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s40337-024-01039-3","volume":"12","author":"A Timek","year":"2024","unstructured":"Timek A, Daniels-Brady C, Ferrando S. Improvement in depressive symptoms in a patient with severe and enduring anorexia nervosa and comorbid major depressive disorder using psychotherapy-assisted IV ketamine: a case report. J Eat Disord. 2024;12(1):79.","journal-title":"J Eat Disord"},{"key":"4929_CR42","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jpsychires.2025.05.055","volume":"188","author":"E Wassenaar","year":"2025","unstructured":"Wassenaar E, Blalock DV, Duffy A, Riddle M, Weeks H, Mehler P, et al. Is ketamine safe for individuals in higher level of care treatment for eating disorders? Analysis of safety of subanesthetic ketamine in 104 patients. J Psychiatr Res. 2025;188:52\u20136.","journal-title":"J Psychiatr Res"},{"issue":"8","key":"4929_CR43","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1007\/s40519-022-01455-x","volume":"27","author":"L Calabrese","year":"2022","unstructured":"Calabrese L, Scolnick B, Zupec-Kania B, Beckwith C, Costello K, Frank GKW. Ketogenic diet and ketamine infusion treatment to target chronic persistent eating disorder psychopathology in anorexia nervosa: a pilot study. Eat Weight Disord. 2022;27(8):3751\u20137.","journal-title":"Eat Weight Disord"},{"issue":"1","key":"4929_CR44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/YCT.0000000000000878","volume":"39","author":"CW Easterly","year":"2023","unstructured":"Easterly CW, Taylor R. Ketamine Augmentation of Electroconvulsive Therapy in an Adolescent Patient With Suicidal Ideation, Disordered Eating, and Type 1 Diabetes Mellitus: A Case Report. J ect. 2023;39(1):63\u20134.","journal-title":"J ect"},{"issue":"1","key":"4929_CR45","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40337-025-01232-y","volume":"13","author":"PJ Escobedo-Aedo","year":"2025","unstructured":"Escobedo-Aedo PJ, Serrand C, Kabani S, Estric C. Ketamine as adjuvant treatment in eating disorders: an exploratory study of a case series and retrospective analysis. J Eat Disord. 2025;13(1):48.","journal-title":"J Eat Disord"},{"issue":"3","key":"4929_CR46","doi-asserted-by":"publisher","first-page":"44","DOI":"10.64719\/pb.4534","volume":"55","author":"K Gao","year":"2025","unstructured":"Gao K, Koparal B, Oruc EB, Musso MA. Electroconvulsive Therapy, Ketamine, and Esketamine in a Patient with Major Depressive Disorder and Multiple Comorbidities: A Case Report over 10-year Treatment from Adolescence to Adulthood. Psychopharmacol Bull. 2025;55(3):44\u201355.","journal-title":"Psychopharmacol Bull"},{"key":"4929_CR47","doi-asserted-by":"publisher","first-page":"1181447","DOI":"10.3389\/fpsyt.2023.1181447","volume":"14","author":"JL Keeler","year":"2023","unstructured":"Keeler JL, Treasure J, Himmerich H, Brendle M, Moore C, Robison R. Case report: Intramuscular ketamine or intranasal esketamine as a treatment in four patients with major depressive disorder and comorbid anorexia nervosa. Front Psychiatry. 2023;14:1181447.","journal-title":"Front Psychiatry"},{"issue":"8","key":"4929_CR48","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1038\/s41591-023-02455-9","volume":"29","author":"SK Peck","year":"2023","unstructured":"Peck SK, Shao S, Gruen T, Yang K, Babakanian A, Trim J, et al. Psilocybin therapy for females with anorexia nervosa: a phase 1, open-label feasibility study. Nat Med. 2023;29(8):1947\u201353.","journal-title":"Nat Med"},{"issue":"1","key":"4929_CR49","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40337-022-00588-9","volume":"10","author":"R Robison","year":"2022","unstructured":"Robison R, Lafrance A, Brendle M, Smith M, Moore C, Ahuja S, et al. A case series of group-based ketamine-assisted psychotherapy for patients in residential treatment for eating disorders with comorbid depression and anxiety disorders. J Eat Disord. 2022;10(1):65.","journal-title":"J Eat Disord"},{"issue":"5","key":"4929_CR50","doi-asserted-by":"publisher","first-page":"e03869","DOI":"10.1002\/ccr3.3869","volume":"9","author":"T Schwartz","year":"2021","unstructured":"Schwartz T, Trunko ME, Feifel D, Lopez E, Peterson D, Frank GK, et al. A longitudinal case series of IM ketamine for patients with severe and enduring eating disorders and comorbid treatment-resistant depression. Clin case Rep. 2021;9(5):e03869.","journal-title":"Clin case Rep"},{"key":"4929_CR51","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3389\/fpsyt.2020.00763","volume":"11","author":"B Scolnick","year":"2020","unstructured":"Scolnick B, Zupec-Kania B, Calabrese L, Aoki C, Hildebrandt T. Remission from Chronic Anorexia Nervosa With Ketogenic Diet and Ketamine: Case Report. Front Psychiatry. 2020;11:763.","journal-title":"Front Psychiatry"},{"issue":"8","key":"4929_CR52","first-page":"777","volume":"179","author":"V Verroust","year":"2021","unstructured":"Verroust V, Zafar R, Spriggs MJ. Psilocybin in the treatment of anorexia nervosa: The English transition of a French 1959 case study. Ann Med Psychol. 2021;179(8):777\u201381.","journal-title":"Ann Med Psychol"},{"key":"4929_CR53","doi-asserted-by":"publisher","first-page":"1141988","DOI":"10.3389\/fpsyt.2023.1141988","volume":"14","author":"PE Wolfson","year":"2023","unstructured":"Wolfson PE, Andries J, Ahlers D, Whippo M. Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses. Front Psychiatry. 2023;14:1141988.","journal-title":"Front Psychiatry"},{"issue":"2","key":"4929_CR54","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/eat.20929","volume":"45","author":"GK Frank","year":"2011","unstructured":"Frank GK, Roblek T, Shott ME, Jappe LM, Rollin MD, Hagman JO, et al. Heightened fear of uncertainty in anorexia and bulimia nervosa. Int J Eat Disord. 2011;45(2):227\u201332.","journal-title":"Int J Eat Disord"},{"issue":"6","key":"4929_CR55","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.janxdis.2011.03.020","volume":"25","author":"L Sternheim","year":"2011","unstructured":"Sternheim L, Startup H, Schmidt U. An experimental exploration of behavioral and cognitive\u2013emotional aspects of intolerance of uncertainty in eating disorder patients. J Anxiety Disord. 2011;25(6):806\u201312.","journal-title":"J Anxiety Disord"},{"issue":"5","key":"4929_CR56","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/erv.2523","volume":"25","author":"M Brown","year":"2017","unstructured":"Brown M, Robinson L, Campione GC, Wuensch K, Hildebrandt T, Micali N. Intolerance of Uncertainty in Eating Disorders: A Systematic Review and Meta-Analysis. Eur Eat Disord Rev. 2017;25(5):329\u201343.","journal-title":"Eur Eat Disord Rev"},{"key":"4929_CR57","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.psychres.2019.01.007","volume":"273","author":"A Bahji","year":"2019","unstructured":"Bahji A, Mazhar MN, Hudson CC, Nadkarni P, MacNeil BA, Hawken E. Prevalence of substance use disorder comorbidity among individuals with eating disorders: A systematic review and meta-analysis. Psychiatry Res. 2019;273:58\u201366.","journal-title":"Psychiatry Res"},{"issue":"1","key":"4929_CR58","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s40337-021-00516-3","volume":"9","author":"DJ Devoe","year":"2021","unstructured":"Devoe DJ, Dimitropoulos G, Anderson A, Bahji A, Flanagan J, Soumbasis A, et al. The prevalence of substance use disorders and substance use in anorexia nervosa: a systematic review and meta-analysis. J Eat Disord. 2021;9(1):161.","journal-title":"J Eat Disord"},{"issue":"1","key":"4929_CR59","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s40337-025-01328-5","volume":"13","author":"S-C Rodan","year":"2025","unstructured":"Rodan S-C, Meez N, Lloyd-Hurwitz S, Bedoya-P\u00e9rez MA, Suraev A, Sommer N, et al. Psychedelic use in individuals living with eating disorders or disordered eating: findings from the international MED\u2013FED survey. J Eat Disord. 2025;13(1):152.","journal-title":"J Eat Disord"},{"issue":"5","key":"4929_CR60","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/erv.3101","volume":"32","author":"K Cuerva","year":"2024","unstructured":"Cuerva K, Spirou D, Cuerva A, Delaquis C, Raman J. Perspectives and preliminary experiences of psychedelics for the treatment of eating disorders: A systematic scoping review. Eur Eat Disord Rev. 2024;32(5):980\u20131001.","journal-title":"Eur Eat Disord Rev"},{"key":"4929_CR61","doi-asserted-by":"crossref","unstructured":"Noblit GW, Hare RD. Meta-Ethnography: SAGE; 1988.","DOI":"10.4135\/9781412985000"},{"issue":"1","key":"4929_CR62","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1186\/s12888-023-05098-9","volume":"23","author":"L Kiely","year":"2023","unstructured":"Kiely L, Conti J, Hay P. Conceptualisation of severe and enduring anorexia nervosa: a qualitative meta-synthesis. BMC Psychiatry. 2023;23(1):606.","journal-title":"BMC Psychiatry"},{"issue":"3","key":"4929_CR63","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/eat.23215","volume":"53","author":"MR Graham","year":"2020","unstructured":"Graham MR, Tierney S, Chisholm A, Fox JRE. The lived experience of working with people with eating disorders: A meta-ethnography. Int J Eat Disord. 2020;53(3):422\u201341.","journal-title":"Int J Eat Disord"},{"key":"4929_CR64","doi-asserted-by":"crossref","unstructured":"Bryant E, Aouad P, Hambleton A, Touyz S, Maguire S. \u2018In an otherwise limitless world, I was sure of my limit.\u2019\u2020 Experiencing Anorexia Nervosa: A phenomenological metasynthesis. Front Psychiatry. 2022; 13","DOI":"10.3389\/fpsyt.2022.894178"},{"key":"4929_CR65","unstructured":"Critical Appraisal Skills Programme UK. CASP Qualitative Studies Checklist 2024 [Available from: https:\/\/casp-uk.net\/casp-tools-checklists\/qualitative-studies-checklist\/"},{"issue":"11","key":"4929_CR66","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1002\/eat.24041","volume":"56","author":"AE Downey","year":"2023","unstructured":"Downey AE, Boyd M, Chaphekar AV, Woolley J, Raymond-Flesch M. But the reality is it\u2019s happening: A qualitative study of eating disorder providers about psilocybin-assisted psychotherapy. Int J Eat Disord. 2023;56(11):2142\u20138.","journal-title":"Int J Eat Disord"},{"issue":"4","key":"4929_CR67","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1080\/02791072.2022.2113484","volume":"55","author":"M Williams","year":"2023","unstructured":"Williams M, Kingston Miller A, Loizaga-Velder A, Files N, Lafrance A. Getting to the root: Ayahuasca ceremony leaders\u2019 perspectives on eating disorders. J Psychoact Drugs. 2023;55(4):425\u201333.","journal-title":"J Psychoact Drugs"},{"issue":"2","key":"4929_CR68","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1080\/10640266.2023.2271201","volume":"32","author":"M Williams","year":"2024","unstructured":"Williams M, Kingston Miller A, Lafrance A. Ayahuasca ceremony leaders\u2019 perspectives on special considerations for eating disorders. Eat Disord. 2024;32(2):120\u201339.","journal-title":"Eat Disord"},{"key":"4929_CR69","doi-asserted-by":"crossref","unstructured":"Finkelstein C, Soha O, Roy A, Phillipou A, Rossell A. Why would you open someone\u2019s brain up? Lived experience insights inform a psilocybin-assisted psychotherapy treatment manual for body image disturbance. Res Square. 2023.","DOI":"10.21203\/rs.3.rs-3189970\/v1"},{"issue":"5","key":"4929_CR70","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/02791072.2017.1361559","volume":"49","author":"A Lafrance","year":"2017","unstructured":"Lafrance A, Loizaga-Velder A, Fletcher J, Renelli M, Files N, Tupper KW. Nourishing the Spirit: Exploratory Research on Ayahuasca Experiences along the Continuum of Recovery from Eating Disorders. J Psychoact Drugs. 2017;49(5):427\u201335.","journal-title":"J Psychoact Drugs"},{"key":"4929_CR71","doi-asserted-by":"crossref","unstructured":"Loh N, Luke D. Exploring the Role of Psychedelic Experiences on Wellbeing and Symptoms of Disordered Eating. Psychoactives. 2025;4(1).","DOI":"10.3390\/psychoactives4010007"},{"key":"4929_CR72","doi-asserted-by":"crossref","unstructured":"Renelli M. The role of ceremonial ayahuasca use and the healing of eating disorders: a qualitiative study. Laurentian University; 2018.","DOI":"10.4324\/9781315159645-17"},{"issue":"2","key":"4929_CR73","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s40519-018-0619-6","volume":"25","author":"M Renelli","year":"2020","unstructured":"Renelli M, Fletcher J, Tupper KW, Files N, Loizaga-Velder A, Lafrance A. An exploratory study of experiences with conventional eating disorder treatment and ceremonial ayahuasca for the healing of eating disorders. Eat Weight Disord. 2020;25(2):437\u201344.","journal-title":"Eat Weight Disord"},{"key":"4929_CR74","doi-asserted-by":"crossref","unstructured":"Plante M, Austin A, Damag S, Tremblay M. Exploring social support for eating disorders in Indigenous contexts. J Eat Disord. 2026;14(1).","DOI":"10.1186\/s40337-026-01574-1"},{"issue":"3","key":"4929_CR75","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.comppsych.2013.12.001","volume":"55","author":"T Brockmeyer","year":"2014","unstructured":"Brockmeyer T, Skunde M, Wu M, Bresslein E, Rudofsky G, Herzog W, et al. Difficulties in emotion regulation across the spectrum of eating disorders. Compr Psychiatry. 2014;55(3):565\u201371.","journal-title":"Compr Psychiatry"},{"issue":"1","key":"4929_CR76","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40479-016-0037-1","volume":"3","author":"C Ruscitti","year":"2016","unstructured":"Ruscitti C, Rufino K, Goodwin N, Wagner R. Difficulties in emotion regulation in patients with eating disorders. Borderline Personal Disord Emot Dysregul. 2016;3(1):3.","journal-title":"Borderline Personal Disord Emot Dysregul"},{"key":"4929_CR77","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.jad.2024.10.017","volume":"369","author":"S F\u00e9lix","year":"2025","unstructured":"F\u00e9lix S, Gon\u00e7alves S, Ramos R, Tavares A, Vaz AR, Machado PPP, et al. Emotion regulation as a transdiagnostic construct across the spectrum of disordered eating in adolescents: A systematic review. J Affect Disord. 2025;369:868\u201385.","journal-title":"J Affect Disord"},{"issue":"1","key":"4929_CR78","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s40337-025-01394-9","volume":"13","author":"E Koning","year":"2025","unstructured":"Koning E, McMillan RM, Keshen A, Hay P, Fernandez AV, Reynolds J, et al. Why psychedelic-assisted therapy studies in eating disorders risk missing the mark on outcomes: a phenomenological psychopathology perspective. J Eat Disord. 2025;13(1):200.","journal-title":"J Eat Disord"},{"issue":"7","key":"4929_CR79","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1080\/08870446.2011.595488","volume":"27","author":"S Williams","year":"2012","unstructured":"Williams S, Reid M. It\u2019s like there are two people in my head\u2019: A phenomenological exploration of anorexia nervosa and its relationship to the self. Psychol Health. 2012;27(7):798\u2013815.","journal-title":"Psychol Health"},{"key":"4929_CR80","doi-asserted-by":"crossref","unstructured":"Adame AL, Pierce E, Jimenez A, Shelby T, Parks D. How Does Self-Identity Change in Eating Disorder Recovery? J Humanist Psychol. 2024.","DOI":"10.1177\/00221678241255264"},{"issue":"1","key":"4929_CR81","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s40337-022-00723-6","volume":"10","author":"JL Keeler","year":"2022","unstructured":"Keeler JL, Konyn CY, Treasure J, Cardi V, Himmerich H, Tchanturia K, et al. Your mind doesn\u2019t have room for anything else: a qualitative study of perceptions of cognitive functioning during and after recovery from anorexia nervosa. J Eat Disord. 2022;10(1):201.","journal-title":"J Eat Disord"},{"issue":"1","key":"4929_CR82","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/jopy.12448","volume":"88","author":"AM Bardone-Cone","year":"2020","unstructured":"Bardone-Cone AM, Thompson KA, Miller AJ. The self and eating disorders. J Pers. 2020;88(1):59\u201375.","journal-title":"J Pers"},{"key":"4929_CR83","doi-asserted-by":"crossref","unstructured":"Cascino G, Castellini G, Stanghellini G, Ricca V, Cassioli E, Ruzzi V et al. The Role of the Embodiment Disturbance in the Anorexia Nervosa Psychopathology: A Network Analysis Study. Brain Sci. 2019;9(10).","DOI":"10.3390\/brainsci9100276"},{"issue":"3","key":"4929_CR84","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/papt.12391","volume":"95","author":"E Monell","year":"2022","unstructured":"Monell E, Clinton D, Birgeg\u00e5rd A. Emotion dysregulation and eating disorder outcome: Prediction, change and contribution of self-image. Psychol Psychother. 2022;95(3):639\u201355.","journal-title":"Psychol Psychother"},{"key":"4929_CR85","doi-asserted-by":"crossref","unstructured":"Verschueren M, Claes L, Palmeroni N, Raemen L, Moons P, Bruckers L et al. Identity Functioning in Patients with an Eating Disorder: Developmental Trajectories throughout Treatment. Nutrients. 2024;16(5).","DOI":"10.3390\/nu16050591"},{"issue":"9","key":"4929_CR86","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1177\/0269881119855974","volume":"33","author":"L Roseman","year":"2019","unstructured":"Roseman L, Haijen E, Idialu-Ikato K, Kaelen M, Watts R, Carhart-Harris R. Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory. J Psychopharmacol. 2019;33(9):1076\u201387.","journal-title":"J Psychopharmacol"},{"key":"4929_CR87","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1136\/jme-2022-108816","volume":"49","author":"D Villiger","year":"2023","unstructured":"Villiger D, Trachsel M. With great power comes great vulnerability: an ethical analysis of psychedelics\u2019 therapeutic mechanisms proposed by the REBUS hypothesis. J Med Ethics. 2023;49:826\u201332.","journal-title":"J Med Ethics"},{"issue":"4","key":"4929_CR88","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/eat.22672","volume":"50","author":"TA Graves","year":"2017","unstructured":"Graves TA, Tabri N, Thompson-Brenner H, Franko DL, Eddy KT, Bourion-Bedes S, et al. A meta-analysis of the relation between therapeutic alliance and treatment outcome in eating disorders. Int J Eat Disord. 2017;50(4):323\u201340.","journal-title":"Int J Eat Disord"},{"issue":"4","key":"4929_CR89","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/cpp.2723","volume":"29","author":"C Babb","year":"2022","unstructured":"Babb C, Jones CRG, Fox JRE. Investigating service users\u2019 perspectives of eating disorder services: A meta-synthesis. Clin Psychol Psychother. 2022;29(4):1276\u201396.","journal-title":"Clin Psychol Psychother"},{"key":"4929_CR90","doi-asserted-by":"crossref","unstructured":"Thal S, Engel LB, Bright SJ. Presence, Trust, and Empathy: Preferred Characteristics of Psychedelic Carers. J Humanist Psychol. 2022:00221678221081380.","DOI":"10.1177\/00221678221081380"},{"key":"4929_CR91","unstructured":"Lindsay B. Footage of therapists spooning and pinning down patient in B.C trial for MDMA therapy prompts review CBC News: CBC News; 2022 [Available from: https:\/\/www.cbc.ca\/news\/canada\/british-columbia\/bc-mdma-therapy-videos-1.6400256"},{"issue":"1","key":"4929_CR92","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1089\/psymed.2024.0011","volume":"3","author":"DJ Kruger","year":"2025","unstructured":"Kruger DJ, Aday JS, Fields CW, Kolbman N, Glynos N, Barron J, et al. Psychedelic Therapist Sexual Misconduct and Other Adverse Experiences Among a Sample of Naturalistic Psychedelic Users. Psychedelic Med. 2025;3(1):41\u20137.","journal-title":"Psychedelic Med"},{"issue":"1","key":"4929_CR93","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1080\/15265161.2024.2433423","volume":"25","author":"TR Harrison","year":"2025","unstructured":"Harrison TR, Faber SC, Zare M, Fontaine M, Williams MT. Wolves Among Sheep: Sexual Violations in Psychedelic-Assisted Therapy. Am J Bioeth. 2025;25(1):40\u201355.","journal-title":"Am J Bioeth"},{"key":"4929_CR94","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.jad.2019.11.028","volume":"263","author":"EE Acevedo-Diaz","year":"2020","unstructured":"Acevedo-Diaz EE, Cavanaugh GW, Greenstein D, Kraus C, Kadriu B, Zarate CA, et al. Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression. J Affect Disord. 2020;263:568\u201375.","journal-title":"J Affect Disord"},{"issue":"1","key":"4929_CR95","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1186\/s12888-022-04268-5","volume":"22","author":"S Ahuja","year":"2022","unstructured":"Ahuja S, Brendle M, Smart L, Moore C, Thielking P, Robison R. Real-world depression, anxiety and safety outcomes of intramuscular ketamine treatment: a retrospective descriptive cohort study. BMC Psychiatry. 2022;22(1):634.","journal-title":"BMC Psychiatry"},{"issue":"44","key":"4929_CR96","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.15585\/mmwr.mm7344a4","volume":"73","author":"AM Vivolo-Kantor","year":"2024","unstructured":"Vivolo-Kantor AM, Mattson CL, Zlotorzysnka M. Notes from the Field: Ketamine Detection and Involvement in Drug Overdose Deaths \u2014 United States, July 2019\u2013June 2023. MMWR Morb Mortal Wkly Rep. 2024;73(44):1010\u20132.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"4929_CR97","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40337-022-00724-5","volume":"11","author":"D Friars","year":"2023","unstructured":"Friars D, Walsh O, McNicholas F. Assessment and management of cardiovascular complications in eating disorders. J Eat Disorders. 2023;11(1):13.","journal-title":"J Eat Disorders"},{"issue":"1","key":"4929_CR98","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40337-023-00751-w","volume":"11","author":"L Puckett","year":"2023","unstructured":"Puckett L. Renal and electrolyte complications in eating disorders: a comprehensive review. J Eat Disorders. 2023;11(1):26.","journal-title":"J Eat Disorders"},{"issue":"4","key":"4929_CR99","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1021\/acsptsci.5c00094","volume":"8","author":"S Hu","year":"2025","unstructured":"Hu S, Lin C, Wang H, Wang X. Psychedelics and Eating Disorders: Exploring the Therapeutic Potential for Anorexia Nervosa and Beyond. ACS Pharmacol Translational Sci. 2025;8(4):910\u20136.","journal-title":"ACS Pharmacol Translational Sci"},{"issue":"1","key":"4929_CR100","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s40337-021-00504-7","volume":"9","author":"CA Levinson","year":"2021","unstructured":"Levinson CA, Hunt RA, Keshishian AC, Brown ML, Vanzhula I, Christian C, et al. Using individual networks to identify treatment targets for eating disorder treatment: a proof-of-concept study and initial data. J Eat Disord. 2021;9(1):147.","journal-title":"J Eat Disord"},{"issue":"3","key":"4929_CR101","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1177\/02698811211069100","volume":"36","author":"AK Schlag","year":"2022","unstructured":"Schlag AK, Aday J, Salam I, Neill JC, Nutt DJ. Adverse effects of psychedelics: From anecdotes and misinformation to systematic science. J Psychopharmacol. 2022;36(3):258\u201372.","journal-title":"J Psychopharmacol"},{"issue":"6","key":"4929_CR102","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1007\/s00213-021-06049-6","volume":"239","author":"D Bender","year":"2022","unstructured":"Bender D, Hellerstein DJ. Assessing the risk\u2013benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research. Psychopharmacology. 2022;239(6):1907\u201332.","journal-title":"Psychopharmacology"},{"key":"4929_CR103","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1176\/appi.ajp.20240378","volume":"182","author":"R Levinstein Marjorie","year":"2025","unstructured":"Levinstein Marjorie R, Budinich Reece C, Bonaventura J, Schatzberg Alan F, Zarate Carlos A, Michaelides M. Redefining Ketamine Pharmacology for Antidepressant Action: Synergistic NMDA and Opioid Receptor Interactions? Am J Psychiatry. 2025;182:247\u201358.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"4929_CR104","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/02698811241303597","volume":"39","author":"G Ingrosso","year":"2025","unstructured":"Ingrosso G, Cleare AJ, Juruena MF. Is there a risk of addiction to ketamine during the treatment of depression? A systematic review of available literature. J Psychopharmacol. 2025;39(1):49\u201365.","journal-title":"J Psychopharmacol"},{"key":"4929_CR105","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ynstr.2018.09.001","volume":"9","author":"CE Strong","year":"2018","unstructured":"Strong CE, Kabbaj M. On the safety of repeated ketamine infusions for the treatment of depression: Effects of sex and developmental periods. Neurobiol Stress. 2018;9:166\u201375.","journal-title":"Neurobiol Stress"},{"issue":"1","key":"4929_CR106","doi-asserted-by":"publisher","first-page":"e2552505","DOI":"10.1001\/jamanetworkopen.2025.52505","volume":"9","author":"AL McGuire","year":"2026","unstructured":"McGuire AL, Neitzke-Spruill L, Robinson JO, Beit CS, Singh N, Mathai DS, et al. Reported Safety Practices of Publicly Advertised Psychedelic Retreats. JAMA Netw Open. 2026;9(1):e2552505\u2013e.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"4929_CR107","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1038\/s41598-024-54642-4","volume":"14","author":"RG McAlpine","year":"2024","unstructured":"McAlpine RG, Sacchet MD, Simonsson O, Khan M, Krajnovic K, Morometescu L, et al. Development of a digital intervention for psychedelic preparation (DIPP). Sci Rep. 2024;14(1):4072.","journal-title":"Sci Rep"},{"issue":"3","key":"4929_CR108","first-page":"189","volume":"34","author":"N Statharakos","year":"2025","unstructured":"Statharakos N, Papadopoulou E, Alvares AJ, Mara A. From bad trips to transformative and potentially therapeutic trips: harnessing the potential of psychedelics - narrative review. Postep Psychiatr Neurol. 2025;34(3):189\u201395.","journal-title":"Postep Psychiatr Neurol"},{"key":"4929_CR109","doi-asserted-by":"crossref","unstructured":"Bremler R, Katati N, Shergill P, Erritzoe D, Carhart-Harris RL. Case analysis of long-term negative psychological responses to psychedelics. Sci Rep. 2023;13.","DOI":"10.1038\/s41598-023-41145-x"},{"issue":"1","key":"4929_CR110","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12888-024-06303-z","volume":"25","author":"J Perna","year":"2025","unstructured":"Perna J, Trop J, Palitsky R, Bosshardt Z, Vantine H, Dunlop BW, et al. Prolonged adverse effects from repeated psilocybin use in an underground psychedelic therapy training program: a case report. BMC Psychiatry. 2025;25(1):184.","journal-title":"BMC Psychiatry"},{"issue":"4","key":"4929_CR111","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/erv.1056","volume":"19","author":"J Treasure","year":"2011","unstructured":"Treasure J, Crane A, McKnight R, Buchanan E, Wolfe M. First do no harm: Iatrogenic Maintaining Factors in Anorexia Nervosa. Eur Eat Disorders Rev. 2011;19(4):296\u2013302.","journal-title":"Eur Eat Disorders Rev"},{"key":"4929_CR112","doi-asserted-by":"crossref","unstructured":"Okano L, Jones G, Deyo B, Brandenburg A, Hale W. Therapeutic setting as an essential component of psychedelic research methodology: Reporting recommendations emerging from clinical trials of 3,4-methylenedioxymethamphetamine for post-traumatic stress disorder. Front Psychiatry. 2022;13:2022.","DOI":"10.3389\/fpsyt.2022.965641"},{"key":"4929_CR113","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jcbs.2019.11.002","volume":"15","author":"J Sloshower","year":"2020","unstructured":"Sloshower J, Guss J, Krause R, Wallace RM, Williams MT, Reed S, et al. Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frame. J Contextual Behav Sci. 2020;15:12\u20139.","journal-title":"J Contextual Behav Sci"},{"key":"4929_CR114","doi-asserted-by":"crossref","unstructured":"Guss J, Krause R, Sloshower J. The Yale manual for psilocybin-assisted therapy of depression (using acceptance and commitment therapy as a therapeutic frame). PsyArXiv. 2020.","DOI":"10.31234\/osf.io\/u6v9y"},{"key":"4929_CR115","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jcbs.2022.08.005","volume":"26","author":"CM Onnink","year":"2022","unstructured":"Onnink CM, Konstantinidou Y, Karekla MK, Merwin RM. Acceptance and Commitment Therapy (ACT) for Eating Disorders: A Systematic Review of Intervention Studies and Call to Action. J Contextual Behav Sci. 2022;26:11\u201328.","journal-title":"J Contextual Behav Sci"},{"key":"4929_CR116","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3389\/fpsyt.2019.00650","volume":"10","author":"AA Feduccia","year":"2019","unstructured":"Feduccia AA, Jerome L, Yazar-Klosinski B, Emerson A, Mithoefer MC, Doblin R. Breakthrough for trauma treatment: safety and efficacy of MDMA-assisted psychotherapy compared to paroxetine and sertraline. Front Psychiatry. 2019;10:650.","journal-title":"Front Psychiatry"},{"key":"4929_CR117","doi-asserted-by":"crossref","unstructured":"Rose JR. From Isolation to Social (and Psychedelic) Integration: A Sociology of Collective Effervescence and Therapeutic Community in Psychedelic-Assisted Therapy. Sociol Health Illn. 2024;47(1).","DOI":"10.1111\/1467-9566.13872"},{"issue":"1","key":"4929_CR118","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40337-022-00588-9","volume":"10","author":"R Robison","year":"2022","unstructured":"Robison R, Lafrance A, Brendle M, Smith M, Moore C, Ahuja S, et al. A case series of group-based ketamine-assisted psychotherapy for patients in residential treatment for eating disorders with comorbid depression and anxiety disorders. J Eat Disorders. 2022;10(1):65.","journal-title":"J Eat Disorders"},{"key":"4929_CR119","doi-asserted-by":"crossref","unstructured":"Celidwen Y, Redvers N, Githaiga C, Calamb\u00e1s J, A\u00f1a\u00f1os K, Chindoy ME et al. Ethical principles of traditional Indigenous medicine to guide western psychedelic research and practice. Lancet Reg Health Am. 2023;18.","DOI":"10.1016\/j.lana.2022.100410"},{"issue":"1","key":"4929_CR120","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1556\/2054.2019.015","volume":"4","author":"JR George","year":"2020","unstructured":"George JR, Michaels TI, Sevelius J, Williams MT. The psychedelic renaissance and the limitations of a White-dominant medical framework: A call for indigenous and ethnic minority inclusion. J Psychedelic Stud. 2020;4(1):4\u201315.","journal-title":"J Psychedelic Stud"},{"key":"4929_CR121","doi-asserted-by":"crossref","unstructured":"Magar V, Robbins M, Fern\u00e1ndez \u00d3ML, Ali IL, Anderson B, Grob C et al. Indigenous Knowledge Systems & Psychedelic Science: Towards Ethical and Reciprocal Collaboration. J Psychopharmacol. 2026.","DOI":"10.1177\/02698811251387104"},{"issue":"9","key":"4929_CR122","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s40263-020-00748-y","volume":"34","author":"JJ Breeksema","year":"2020","unstructured":"Breeksema JJ, Niemeijer AR, Krediet E, Vermetten E, Schoevers RA. Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies. CNS Drugs. 2020;34(9):925\u201346.","journal-title":"CNS Drugs"},{"issue":"2","key":"4929_CR123","doi-asserted-by":"publisher","first-page":"116","DOI":"10.5617\/jea.7365","volume":"3","author":"S Harris","year":"2019","unstructured":"Harris S. Narrating the unspeakable: making sense of psychedelic experiences in drug treatment. J extreme Anthropol. 2019;3(2):116\u201340.","journal-title":"J extreme Anthropol"},{"key":"4929_CR124","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1037\/rel0000043","volume":"8","author":"D Yaden","year":"2015","unstructured":"Yaden D, Eichstaedt J, Schwartz H, Kern M, Le Nguyen K, Wintering N, et al. The Language of Ineffability: Linguistic Analysis of Mystical Experiences. Psycholog Relig Spiritual. 2015;8:244\u201352.","journal-title":"Psycholog Relig Spiritual"},{"key":"4929_CR125","doi-asserted-by":"publisher","first-page":"101859","DOI":"10.1016\/j.aip.2021.101859","volume":"76","author":"C Griffin","year":"2021","unstructured":"Griffin C, Fenner P, Landorf KB, Cotchett M. Effectiveness of art therapy for people with eating disorders: A mixed methods systematic review. Arts Psychother. 2021;76:101859.","journal-title":"Arts Psychother"},{"issue":"4","key":"4929_CR126","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1136\/medhum-2022-012573","volume":"49","author":"N Eren","year":"2023","unstructured":"Eren N, Tunc P, Y\u00fccel B. Effect of a long-term art-based group therapy with eating disorders. Med Humanit. 2023;49(4):576.","journal-title":"Med Humanit"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04929-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04929-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04929-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:02:18Z","timestamp":1783692138000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04929-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":126,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4929"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04929-2","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"HH, JLK, and JT report funding from the UK Medical Research Centre (MRC) for a double-blinded randomised controlled trial to test oral ketamine in people with anorexia nervosa and depression (MR\/Y019504\/1). HH was the principal investigator of a phase 2 clinical trial investigating the efficacy and safety of investigational COMP360 psilocybin treatment in anorexia nervosa.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}}],"article-number":"392"}}